AUSTIN, Texas — Equus Health Solutions Inc., one of the world’s largest health care companies, is a global leader in medical devices and health care delivery solutions.
The company has become known for the innovative products it provides for patients and their families and its focus on wellness, which is evident in its products’ high quality, value and customer satisfaction ratings.
Equus Healthcare, the world leader in the medical devices industry, has become a major player in the U.S. healthcare sector with sales totaling $3,567.8 billion last year, a rise of 9% from the prior year.
It also has become an important investor in other U.P. markets including the United Kingdom, Canada, Australia and New Zealand, with a portfolio worth more than $1.5 trillion.
In addition to healthcare products, Equus is the world leaders in telehealth and has been growing rapidly for more than a decade.
The equities company, based in Austin, Texas, reported revenue of $3 billion in fiscal 2014, a 22% increase over fiscal 2013.
The growth rate accelerated to $4.6 billion in FY15 and is expected to increase to $5 billion by FY20, according to a presentation provided by Equus.
For the fiscal year that ended Sept. 30, Equuss reported a $1 billion operating loss and an adjusted loss of $1,719 million, or $5.5 per share, according a company release.
The annual revenue growth rate of 10% is more than double the industry average of 3% and equus has outperformed the S&P 500 Index by more than 10%.
The company has continued to grow revenue with a strong emphasis on medical device sales and revenue growth in the healthcare sector.
According to a statement from Equus, medical device revenue rose 9% in fiscal 2015 and the growth rate was driven by the launch of the first generation of Equus Medtech.
The first generation, the first to be released commercially, has the potential to grow sales to more than one billion by 2020.
The company is in the process of launching a second generation of Medtech, the new generation, which will deliver improved features and a lower cost, and equuss Healthcare is developing the third generation Medtech and is evaluating other Medtech models that are in the pipeline.
Equus Healthcare also announced a $5 million investment in the United States, a significant amount given the company’s recent investments in other countries, including the U, K and T-Rex, the largest healthcare markets in the world.
The growth of the equus healthcare business is driven by growing revenue from the healthcare market.
The medical device market has been the primary driver of Equuss’ growth, with sales increasing 9% during the same period.
In the medical device segment, equuss healthcare revenues rose 4% from $3 million in fiscal 2013 to $7 million in FY14.
The healthcare segment is responsible for nearly 40% of EquUS healthcare revenues and is projected to continue to be a major driver of equus profits in the next several years, according the company.
In its earnings release, Equaus noted that healthcare revenue has increased by 11% year over year in the fiscal 2015 quarter.
The increase is driven primarily by the growth in healthcare revenue as healthcare costs have been reduced.
The Healthcare sector is expected be a strong driver of profit growth in FY2020, the company said.
Equuss is the second-largest healthcare company in the Fortune 500.
It was ranked number two in the 2014 Forbes 400 list, the highest ranking it has ever achieved, and its stock price has been up more than 90% over the past four years.
Equuses stock price climbed nearly 25% from last year’s close to $32.95 on Friday, which was the highest in five years.
Equuss stock closed at $34.90 on Friday.